title: Value-based insurance plus disease management increased medication use and produced savings.
abstract: We evaluated the effects of implementing a value-based insurance design program for patients with diabetes in two groups within a single firm. One group participated in disease management; the other did not. We matched members of the two groups to similar enrollees within the company that did not offer the value-based program. We found that participation in both value-based insurance design and disease management resulted in sustained improvement over time. Use of diabetes medications increased 6.5 percent over three years. Adherence to diabetes medical guidelines also increased, producing a return on investment of $1.33 saved for every dollar spent during a three-year follow-up period.
authors.affiliation: Thomson Reuters, Ann Arbor, Michigan, USA. teresa.gibson@thomsonreuters.com
authors.forename: Teresa B
authors.initials: TB
authors.lastname: Gibson
authors.forename: John
authors.initials: J
authors.lastname: Mahoney
authors.forename: Karlene
authors.initials: K
authors.lastname: Ranghell
authors.forename: Becky J
authors.initials: BJ
authors.lastname: Cherney
authors.forename: Newell
authors.initials: N
authors.lastname: McElwee
mesh_terms: D017046:Cost Savings; D003669:Deductibles and Coinsurance / Q000191:economics; D003920:Diabetes Mellitus / Q000191:economics* / Q000628:therapy; D019468:Disease Management; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use; D007348:Insurance, Health / Q000191:economics*; D008297:Male; D008875:Middle Aged; D017059:Models, Econometric; D010349:Patient Compliance
chemical_list: D007004:Hypoglycemic Agents